Two drugs facing key patent expirations and potential generic entry from July to August 2020.

Authors :: Friedman Y
Source :: Pharmaceutical patent analyst [Pharm Pat Anal] 2020 Jul; Vol. 9 (4), pp. 137-138.
Publication Year :: 2020
Abstract: A challenge in anticipating generic entry is elucidating which patents and regulatory protections constrain generic entry.

Subjects :: Anisoles economics
Ciprofloxacin economics
Dexamethasone economics
Drug Combinations
Drug Industry economics
Drug Industry legislation & jurisprudence
Drugs, Generic administration & dosage
Drugs, Generic economics
Humans
Patents as Topic
Tretinoin economics
United States
Anisoles administration & dosage
Ciprofloxacin administration & dosage
Dexamethasone administration & dosage
Tretinoin administration & dosage

Full Text Access

Tools